NCT07332533 2026-01-12A Study of KN026-based Combination Therapy in HER2-positive Gastric CancerShanghai JMT-Bio Inc.Phase 2/3 Not yet recruiting490 enrolled
NCT06439550 2024-06-03Adjuvant Treatment With Serplulimab，Trastuzumab and SOX in the HER-2 Positive GC/GEJCThe First Affiliated Hospital of Zhengzhou UniversityPhase 2 Not yet recruiting42 enrolled